Marc Hermann set out to build a healthcare company focused on catching disease before it strikes. Investors have backed that vision with a $65 million funding round. Everlab has raised $65 million at a valuation approaching $500 million, marking what appears to be Australia’s largest medtech capital raise of the year, cementing the Melbourne-based preventive […]
The Queensland cattle farmer’s daughter behind Swipejobs spent 30 years studying how people get hired. Now she is eyeing a multi-billion dollar IPO. Subscribe to Forbes Australia for full access to this and all articles today Subscribe Already a subscriber? Sign In
The Carlton captain has joined BFT founder Cameron Falloon and a group of investors backing Stille, a $10 million Melbourne wellness club that promises elite-athlete recovery tools for everybody – at $200 a week. Patty Cripps spends plenty of time thinking about how to squeeze a few more years out of his AFL career. The […]
Former pharma executive Karinza Phoenix is raising $5 million and preparing an ASX listing as Myopharm advances a diabetes drug it hopes can complement the GLP-1 giants. Karinza Phoenix hasn’t found it hard raising the $6 million that’s got her biotech firm, Myopharm, onto the fast-track approval process for its Type 2 diabetes drug. “How […]
A chance conversation on a golf course has drawn the former Wallaby and listed-company CEO into a regional manufacturing venture aiming to decarbonise one of the world’s dirtiest industries. Former Wallaby great Phil Kearns was no great fan of Scope 3 emissions requirements and all the other rigmarole he’d had to go through as CEO […]
Melbourne defence-tech start-up Arkeus has raised $25 million on its technology born from a founder seeing the frustration of drone operators hunting drugs in the Colombian jungle. Key Takeaways Key Background Simon Olsen was in the jungles of La Macarena, Colombia, where the Andes and Amazon meet, looking for drug operations, when the realisation hit. […]
From BHP’s $300 million nickel crisis to the reinvention of private banking, Geraldine Slattery and Susie Grehl reveal why the most dangerous move a leader can make in an era of rapid disruption is doing nothing at all. When Geraldine Slattery was making her way up through the ranks at BHP, her mentors encouraged her […]
Tetratherix built a $255 million ASX company around a single injectable polymer. Now that same material is being used in everything from dental surgery to prostate cancer treatment and GLP-1 delivery. Tetratherix grabbed the market’s attention in March when it announced its patented polymer was going to be used for the slow release of GLP-1 […]
Julie Inman Grant once taught “social media self-defence” to women in public life. Then came the online pile-on from Elon Musk’s followers – and she found herself taking her own advice. When eSafety Commissioner Julie Inman Grant was branded Australia’s “censorship commissar” by Elon Musk in 2024, the fallout came fast: 75,000 posts in 24 […]
Vikas Rambal built the world’s largest ammonia plant, walked away with hundreds of millions, lost everything that mattered – then did it again. And Australia barely noticed. This story features on the cover of Issue 22 – out now. Tap here to secure your copy or become a Forbes member here. Vikas Rambal can’t believe that nobody seems to have heard the stories about […]